Sentence examples for more favourable side from inspiring English sources

That history lesson reinforces the need for Wales to seize their chance in Paris, especially as they are in the more favourable side of the draw.

England's inability to break down Slovakia was widely criticised, though it was arguably their failure to hold out against Russia that ultimately cost them a spot on the more favourable side of the draw.

Here, we show that a fixed low dose of topiramate 25 mg/day is efficacious in migraine prophylaxis and also attest to advantages in terms of medication cost savings and more favourable side effect profile.

France coach Marc Lievremont insists his team will aim to win against New Zealand on Saturday, despite picking a weakened team, leading to suggestions he was happy to lose and thus qualify from Pool A into the more favourable side of the draw.

Based on its selectivity it has a more favourable side effect profile.

An IFN with potent antiviral effects and a more favourable side effect profile would revolutionise the treatment of HCV.

On theoretical grounds they have a more favourable side-effect profile.

The pharmacodynamic differences between biologically targeted agents and standard chemotherapeutics may explain why gefitinib has a more favourable side-effect profile than some traditional chemotherapies.

In advanced disease, in the first-line setting, anastrozole, letrozole and exemestane have proved to be more clinically efficient than tamoxifen in prospective randomised trials and demonstrate a more favourable side-effect profile (Bonneterre et al, 2000; Nabholtz et al, 2000; Paridaens et al, 2000, 2003; Mouridsen et al, 2001; Howell et al, 2003).

Adjuvant AI therapy is now the standard of care for postmenopausal women with HR+ BC because of its superior disease-free survival results and more favourable side-effect profile (particularly with regard to venous thrombosis and endometrial cancers) compared with tamoxifen (Howell et al, 2005; Thurlimann et al, 2005; Coombes et al, 2007).

4 The novel oral anticoagulant dabigatran etexilate has been compared with VKA in patients with non-valvular AF in a large phase 3 randomised trial; it has been shown to be non-inferior to VKA with a comparable or lower risk of strokes, and with a more favourable side-effect profile concerning serious bleedings.